Mission Street

Mission Street designs, develops, and operates purpose-built science and innovation real estate serving the life sciences, deep technology, and advanced engineering sectors. The firm's portfolio consists of laboratories, R&D facilities, and specialist office space within university-linked innovation districts in the UK, Europe, and Asia-Pacific.

Mission Street primarily originates projects through long-term partnership agreements with universities, research institutions, and public-sector science park authorities rather than through competitive property auctions. This embedded origination model gives the firm early visibility into tenant demand and unusual control over design specifications, creating high barriers to entry for generic commercial developers.

Mission Street typically forms joint ventures with institutional investors and sovereign capital, leveraging its specialist operator status to attract long-duration funding. While the firm does not publicly disclose its limited partner roster, its structure implies partnerships with pension schemes, insurers, and sovereign wealth funds seeking inflation-linked, infrastructure-like cash flows from science real estate.

No. The firm has offices in London, Singapore, Utrecht, and Beijing, and its multi-jurisdictional operational footprint is consistent with an institutional asset management and development platform rather than a single-family office structure. There is no public disclosure of a family wealth origin.

Mission Street operates across the UK, continental Europe, and Asia-Pacific, with a particular focus on university-anchored innovation districts. The firm maintains physical offices in London, Utrecht, Singapore, and Beijing, reflecting its active development pipeline in these regions.